Ladan Zand, MD, and others examined the efficacy and safety of obinutuzumab, a type II anti-CD20 antibody, to treat patients with focal segmental glomerulosclerosis (FSGS) who were treatment-resistant or dependent on immunosuppressive therapy. They reported findings in a poster presented at ASN Kidney Week 2024, titled Single-Center, Phase 2, Open-Label Trial Evaluating the Efficacy and Safety of Obinutuzumab in Treatment of Immunosuppression-Resistant Primary FSGS, or Contraindication to High-Dose Corticosteroids. ...
Nephrology Times
Nephrology Times delivers the latest news in kidney-related treatments and technologies with the goal of better informing care decisions and improving patient outcomes.
Advertisement
Latest News
RGLS8429 increases urinary PC1 and PC1 proteins, which may help reduce height-adjusted total kidney volume in ADPKD.
Researchers evaluated the efficacy of sparsentan in a subset of patients with genetic focal segmental glomerulosclerosis.
Len Usvyat spoke with Nephrology Times about the use of artificial intelligence in kidney care.
A study examined whether urate-lowering therapy (ULT) for gout might help delay progression of chronic kidney disease (CKD).
Could pravastatin slow the rate of increase in height-adjusted total kidney volume in adults with ADPKD?
Could the use of potassium binder SZC with dialysate potassium reduce postdialysis heart arrhythmias?
A study examined the efficacy of adding SZC to allow patients with stage 3-4 DKD to maintain treatment with RAASi.
Researchers assessed the safety and efficacy of bardoxolone methyl (BARD) in patients with ADPKD.
Vlado Perkovic spoke about findings from the FLOW, APPLAUSE-IgAN, and CREDENCE trials presented at ASN Kidney Week.
A study examined prognosis and lifespan of adults who received kidney replacement therapy as children.
Advertisement
Expert Interviews
In Print
ASN Kidney Week 2024, the future of nephrology, the relationship between CKD and osteoarthritis, and more.
Tribute to Nicoloas Madias, amino acid infusion to reduce AKI risk, felzartamab results, and more.
Conferences
The American Society of Nephrology's annual meeting to highlight the latest scientific and medical advances in the field
ATC provides a forum for exchange of new scientific and clinical information relevant to transplantation.
The annual nephrology meeting organized by the European Renal Association
The National Kidney Foundation's premier educational event designed for the interprofessional kidney health team
Podcasts
The Filtrate rerecorded their episode on the PRAECIS trial regarding a blood test for preeclampsia due to listener feedback.
We had a great NephJC get together. We recorded the whole event and packaged it into a podcast.
Amino acid infusions to prevent AKI? It couldn’t be that simple, could it?
Listen to the second part of the discussion of Chapter 15 of Dr. Burton Rose's book, focused on diuretics.
Expert Columns
It is important to understand the challenges Medicare Advantage plans present for ESRD care.
Critical Financial Shifts Ahead: How CY 2025 ESRD PPS Changes Could Impact Small Dialysis Facilities
Sarah Tolson reviews the key financial implications of the CMS proposed rule for the ESRD Prospective Payment System.
Ajay Singh pays tribute to the late nephrologist and researcher Nicolaos Madias, MD, of Tufts Medical Center.
The four-pillar approach to treating diabetic kidney disease (DKD) has been endorsed by high-quality trials, such as FLOW.
It is essential for nephrology practices and dialysis centers to have backup methods for processing claims.
IgA nephropathy (IgAN) is on the cusp of a transformational change in its treatment.
Knowledge Hubs
Advertisement
Advertisement
Nephrology Times Chair
Ajay K. Singh, MBBS, FRCP, MBASenior Nephrologist, Brigham and Women’s Hospital | Senior Associate Dean, Harvard Medical School
Editorial Board
Mohamed G. Atta, MD, MPHProfessor of Medicine, Johns Hopkins School of Medicine
Timothy E. Bunchman, MDProfessor and Director, Pediatric Nephrology, Transplantation, and Rheumatology, Children’s Hospital of Richmond at VCU
Suphamai Bunnapradist, MD, MSProfessor of Medicine, David Geffen School of Medicine at UCLA | Research Director, Kidney Transplant Program, UCLA
Fernando C. Fervenza, MD, PhDProfessor of Medicine, Division of Nephrology and Hypertension, Mayo Clinic
Kenneth A. Liss, DOPartner, Hypertension and Nephrology Association, Eatontown, NJ
Joel M. Topf, MD, FACPAssistant Clinical Professor of Medicine, Oakland University William Beaumont School of Medicine
© 2024 Mashup Media, LLC, a Formedics Property. All Rights Reserved.